Matches in Wikidata for { <http://www.wikidata.org/entity/Q87262274> ?p ?o ?g. }
Showing items 1 to 90 of
90
with 100 items per page.
- Q87262274 description "artículu científicu espublizáu n'ochobre de 2013" @default.
- Q87262274 description "im Oktober 2013 veröffentlichter wissenschaftlicher Artikel" @default.
- Q87262274 description "scientific article published on 01 October 2013" @default.
- Q87262274 description "wetenschappelijk artikel" @default.
- Q87262274 description "наукова стаття, опублікована в жовтні 2013" @default.
- Q87262274 name "Saxagliptin add-on therapy to insulin with or without metformin for type 2 diabetes mellitus: 52-week safety and efficacy" @default.
- Q87262274 name "Saxagliptin add-on therapy to insulin with or without metformin for type 2 diabetes mellitus: 52-week safety and efficacy" @default.
- Q87262274 type Item @default.
- Q87262274 label "Saxagliptin add-on therapy to insulin with or without metformin for type 2 diabetes mellitus: 52-week safety and efficacy" @default.
- Q87262274 label "Saxagliptin add-on therapy to insulin with or without metformin for type 2 diabetes mellitus: 52-week safety and efficacy" @default.
- Q87262274 prefLabel "Saxagliptin add-on therapy to insulin with or without metformin for type 2 diabetes mellitus: 52-week safety and efficacy" @default.
- Q87262274 prefLabel "Saxagliptin add-on therapy to insulin with or without metformin for type 2 diabetes mellitus: 52-week safety and efficacy" @default.
- Q87262274 P1433 Q87262274-902AD370-5C72-4140-A9E6-DA23731F6EE2 @default.
- Q87262274 P1476 Q87262274-86ADDBA1-5F6F-4BC9-BF8A-4B08CD42FB0A @default.
- Q87262274 P2093 Q87262274-356C78C3-4F4D-4BA7-890D-094F9D669522 @default.
- Q87262274 P2093 Q87262274-3F6433E8-4761-445B-86C4-85122B175355 @default.
- Q87262274 P2093 Q87262274-9C40432E-3A68-4668-A9DC-2086904AEA6A @default.
- Q87262274 P2093 Q87262274-CB333254-B182-44DD-ACDF-CEB8421B2748 @default.
- Q87262274 P2093 Q87262274-EE05146E-C08C-4D30-9DCB-38DF32A0369D @default.
- Q87262274 P2093 Q87262274-FFCC3F5B-F2D2-4B68-A745-2175946C5602 @default.
- Q87262274 P2860 Q87262274-0F35FAFD-537C-46DD-B2B4-AE38148757C8 @default.
- Q87262274 P2860 Q87262274-30E55687-5158-4FBF-AA67-F2C4BF12B074 @default.
- Q87262274 P2860 Q87262274-361F398C-FAC3-4DC8-8085-AB72BCB01A6D @default.
- Q87262274 P2860 Q87262274-3F709C3B-C936-4602-87C2-7A50FF48B64C @default.
- Q87262274 P2860 Q87262274-41B17757-9D86-466D-92A8-FE8F4C277E4C @default.
- Q87262274 P2860 Q87262274-54A5F28F-36B0-4B81-B802-60FDB7D32CE1 @default.
- Q87262274 P2860 Q87262274-58E2BFD0-E73A-419B-910B-CE2BA2E2D6AB @default.
- Q87262274 P2860 Q87262274-6F7B465D-8288-46C8-AC63-4E288BBC45E6 @default.
- Q87262274 P2860 Q87262274-86C52A49-2C8F-4963-9A51-91EBC7E1C819 @default.
- Q87262274 P2860 Q87262274-88C35B45-66A8-4E0B-8CD4-6B088B3CB915 @default.
- Q87262274 P2860 Q87262274-8DB21125-D890-4D2E-9E38-16CE03CE7CF7 @default.
- Q87262274 P2860 Q87262274-9698B9DA-0B8F-43AE-AD82-E7D77BAE7777 @default.
- Q87262274 P2860 Q87262274-9D2DE94F-ED88-4DA9-B289-CBB8F46EBC58 @default.
- Q87262274 P2860 Q87262274-A6A42560-581D-4D6B-B88F-1A96AEA400B5 @default.
- Q87262274 P2860 Q87262274-AE7CEAE9-19D4-4541-A8F7-75FA9716F869 @default.
- Q87262274 P2860 Q87262274-B784E370-0490-40DF-85E0-710B037C20FA @default.
- Q87262274 P2860 Q87262274-C6C2C0CA-F0ED-4F80-A3CF-E7D0686164C8 @default.
- Q87262274 P2860 Q87262274-CCB457A9-2F6C-4CD4-9C11-F4A93F92B581 @default.
- Q87262274 P2860 Q87262274-E1D35756-B31E-4A15-B66B-CCF9164FA3BE @default.
- Q87262274 P2860 Q87262274-E51F4A85-DBE8-4751-80ED-34BCA6747A4A @default.
- Q87262274 P2860 Q87262274-F4286CAD-6C02-4497-AF93-69C6C2BD4C40 @default.
- Q87262274 P304 Q87262274-C87BDD6B-667F-4E07-8502-2EEEAA5DD505 @default.
- Q87262274 P31 Q87262274-1D4AC0A1-08B7-48FF-9A8C-7D010D6FDE27 @default.
- Q87262274 P356 Q87262274-98D1BD16-89C5-4E6C-B2D0-6C44A8180033 @default.
- Q87262274 P433 Q87262274-EBB4D8CC-AD9B-4236-91CA-0EC6A1BD99EB @default.
- Q87262274 P478 Q87262274-4A838B04-2298-4CB2-B586-1A24DF88B805 @default.
- Q87262274 P577 Q87262274-648A4983-1FD0-4D11-981C-0650A8DC782B @default.
- Q87262274 P698 Q87262274-51F1A73F-6907-44E6-9405-A1C57B5A6151 @default.
- Q87262274 P921 Q87262274-AD5213EA-141C-451D-8906-8B7AAA8AA955 @default.
- Q87262274 P921 Q87262274-D4D6FEA6-48F6-4DF0-A465-3086A70A5185 @default.
- Q87262274 P356 S40261-013-0107-8 @default.
- Q87262274 P698 23949898 @default.
- Q87262274 P1433 Q15753215 @default.
- Q87262274 P1476 "Saxagliptin add-on therapy to insulin with or without metformin for type 2 diabetes mellitus: 52-week safety and efficacy" @default.
- Q87262274 P2093 "Anthony H Barnett" @default.
- Q87262274 P2093 "Bernard Charbonnel" @default.
- Q87262274 P2093 "Douglas Fleming" @default.
- Q87262274 P2093 "Jia Li" @default.
- Q87262274 P2093 "Mark Donovan" @default.
- Q87262274 P2093 "Nayyar Iqbal" @default.
- Q87262274 P2860 Q22241288 @default.
- Q87262274 P2860 Q28762629 @default.
- Q87262274 P2860 Q34374321 @default.
- Q87262274 P2860 Q34565168 @default.
- Q87262274 P2860 Q34648377 @default.
- Q87262274 P2860 Q34692143 @default.
- Q87262274 P2860 Q35673057 @default.
- Q87262274 P2860 Q35861736 @default.
- Q87262274 P2860 Q37621774 @default.
- Q87262274 P2860 Q37710723 @default.
- Q87262274 P2860 Q37784644 @default.
- Q87262274 P2860 Q37793738 @default.
- Q87262274 P2860 Q37825600 @default.
- Q87262274 P2860 Q37835611 @default.
- Q87262274 P2860 Q38378882 @default.
- Q87262274 P2860 Q43187035 @default.
- Q87262274 P2860 Q43275817 @default.
- Q87262274 P2860 Q45250947 @default.
- Q87262274 P2860 Q46653146 @default.
- Q87262274 P2860 Q51361433 @default.
- Q87262274 P2860 Q56914456 @default.
- Q87262274 P304 "707-717" @default.
- Q87262274 P31 Q13442814 @default.
- Q87262274 P356 "10.1007/S40261-013-0107-8" @default.
- Q87262274 P433 "10" @default.
- Q87262274 P478 "33" @default.
- Q87262274 P577 "2013-10-01T00:00:00Z" @default.
- Q87262274 P698 "23949898" @default.
- Q87262274 P921 Q19484 @default.
- Q87262274 P921 Q3025883 @default.